Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,222
datasets available to search
ShareScore release 0.9.0
Dataset results
6,222 results for “small cells”
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02250326. IPD Sharing: Not stated. Countries: 7. Publications: 32.
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01459497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors
ClinicalTrials.gov study NCT02920996. IPD Sharing: NO. Countries: 1. Publications: 1.
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00367601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
ClinicalTrials.gov study NCT02566993. IPD Sharing: Not stated. Countries: 20. Publications: 1.
Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT02748889. IPD Sharing: NO. Countries: 1. Publications: 6.
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00949910. IPD Sharing: Not stated. Countries: 51. Publications: 2.
A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lun
ClinicalTrials.gov study NCT05171777. IPD Sharing: YES. Countries: 12. Publications: 1.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT00305942. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02855281. IPD Sharing: NO. Countries: 1. Publications: 1.
BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00411632. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
ClinicalTrials.gov study NCT02544633. IPD Sharing: NO. Countries: 9. Publications: 2.
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03794544. IPD Sharing: YES. Countries: 7. Publications: 1.
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression F
ClinicalTrials.gov study NCT00993499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
ClinicalTrials.gov study NCT03066778. IPD Sharing: YES. Countries: 19. Publications: 1.
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00326599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02771626. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Lea
ClinicalTrials.gov study NCT02409368. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT02016872. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.